These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 4508924

  • 1. Hemorrhagic disease associated with inhibitors of fibrin cross-linkage.
    Lewis JH.
    Ann N Y Acad Sci; 1972 Dec 08; 202():213-9. PubMed ID: 4508924
    [No Abstract] [Full Text] [Related]

  • 2. Haemorrhagic syndrome of autoimmune origin with a specific inhibitor against fibrin stabilizing factor (factor XIII).
    Lorand L, Maldonado N, Fradera J, Atencio AC, Robertson B, Urayama T.
    Br J Haematol; 1972 Jul 08; 23(1):17-27. PubMed ID: 5045959
    [No Abstract] [Full Text] [Related]

  • 3. Fibrinoligase: the fibrin-stabilizing factor system of blood plasma.
    Lorand L.
    Ann N Y Acad Sci; 1972 Dec 08; 202():6-30. PubMed ID: 4565370
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of factor XIII activation by an anti-peptide monoclonal antibody.
    Lukacova D, Matsueda GR, Haber E, Reed GL.
    Biochemistry; 1991 Oct 22; 30(42):10164-70. PubMed ID: 1681898
    [Abstract] [Full Text] [Related]

  • 5. An acquired inhibitor of fibrin stabilization associated with isoniazid therapy: clinical and biochemical observations.
    Otis PT, Feinstein DI, Rapaport SI, Patch MJ.
    Blood; 1974 Dec 22; 44(6):771-81. PubMed ID: 4214572
    [No Abstract] [Full Text] [Related]

  • 6. Acquired plasma factor XIII deficiencies.
    Tosetto A, Castaman G, Rodeghiero F.
    Haematologica; 1993 Dec 22; 78(6 Suppl 2):5-10. PubMed ID: 8039759
    [Abstract] [Full Text] [Related]

  • 7. [Effect of sodium para-aminosalicylate on the concentration of isoniazid (tubazid) in the blood of patients with tuberculosis].
    Kozulitsina TI, Korotaev GA.
    Ter Arkh; 1969 Dec 22; 41(10):94-7. PubMed ID: 5359356
    [No Abstract] [Full Text] [Related]

  • 8. A new haemorrhagic disorder with defective fibrin stabilization and cryofibrinogenaemia.
    Rosenberg RD, Colman RW, Lorand L.
    Br J Haematol; 1974 Feb 22; 26(2):269-84. PubMed ID: 4843743
    [No Abstract] [Full Text] [Related]

  • 9. [Factor XIII, its physiological significance (a review of the literature)].
    Baluda VP, Zhukova NA.
    Probl Gematol Pereliv Krovi; 1973 Feb 22; 18(2):34-40. PubMed ID: 4271843
    [No Abstract] [Full Text] [Related]

  • 10. An acquired inhibitor of factor XIII with a qualitative abnormality of fibrin cross-linking.
    Fear JD, Miloszewski KJ, Losowsky MS.
    Acta Haematol; 1984 Feb 22; 71(5):304-9. PubMed ID: 6429995
    [Abstract] [Full Text] [Related]

  • 11. Activation of blood coagulation factor XIII.
    Lorand L.
    Ann N Y Acad Sci; 1986 Feb 22; 485():144-58. PubMed ID: 3471146
    [No Abstract] [Full Text] [Related]

  • 12. An acquired inhibitor to factor XIII A case report.
    Shires L, Gomperts ED, Bradlow BA.
    S Afr Med J; 1979 Jul 14; 56(2):70-2. PubMed ID: 483113
    [Abstract] [Full Text] [Related]

  • 13. Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture.
    Jadhav MA, Goldsberry WN, Zink SE, Lamb KN, Simmons KE, Riposo CM, Anokhin BA, Maurer MC.
    Biochim Biophys Acta Proteins Proteom; 2017 Oct 14; 1865(10):1246-1254. PubMed ID: 28687225
    [Abstract] [Full Text] [Related]

  • 14. Fibrin-stabilizing factor inhibitors.
    Nilsson JL, Stenberg P, Ljunggren C, Hoffman KJ, Lundén R, Eriksson O, Lorand L.
    Ann N Y Acad Sci; 1972 Dec 08; 202():286-96. PubMed ID: 4508928
    [No Abstract] [Full Text] [Related]

  • 15. Difference between type I autoimmune inhibitors of fibrin stabilization in two patients with severe hemorrhagic disorder.
    Lopaciuk S, Bykowska K, McDonagh JM, McDonagh RP, Yount WJ, Fuller CR, Cooperstein L, Gray A, Lorand L.
    J Clin Invest; 1978 May 08; 61(5):1196-203. PubMed ID: 96136
    [Abstract] [Full Text] [Related]

  • 16. [Detection of factor XIII deficiency in acute leukemia with resonance thrombography].
    Anders O, Görss EW, Ernst B, Konrad H.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987 May 08; 114(5):670-9. PubMed ID: 2448208
    [Abstract] [Full Text] [Related]

  • 17. The effect of oral contraceptives on fibrin-clot stabilization.
    Shanberge JN, Tanaka K, Gruhl MC, Ikemori R, Inoshita K.
    Ann N Y Acad Sci; 1972 Dec 08; 202():220-9. PubMed ID: 4508925
    [No Abstract] [Full Text] [Related]

  • 18. [Experimental therapy of tuberculosis with tuberculostatically inactive peptides].
    Rosenfeld M.
    Beitr Klin Erforsch Tuberk Lungenkr; 1965 Dec 08; 132():327-9. PubMed ID: 5885180
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of ACTH and corticosteroids on the fibrin stabilizing factor].
    Seĭfulla RD.
    Farmakol Toksikol; 1969 Dec 08; 32(4):464-5. PubMed ID: 4311479
    [No Abstract] [Full Text] [Related]

  • 20. Regulation of thrombin cleavage of plasma factor XIII bound to fibrin.
    Greenberg CS, Achyuthan KE, Miraglia CC, Dobson JV.
    Ann N Y Acad Sci; 1986 Dec 08; 485():140-3. PubMed ID: 3471145
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.